Moreover, those patients with tumors that were significantly smaller one month after RT had a lower expression of SDH5 (Figure 1B), and the loss of SDH5 expression was correlated with the upregulation of p53, which is the most extensively studied tumor suppressor gene, in the clinical specimens from the lung cancer patients (Figure 1C). This evidence concerns the gene TP53 and lung carcinoma.